Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments, 11902-11903 [2023-03808]

Download as PDF 11902 Federal Register / Vol. 88, No. 37 / Friday, February 24, 2023 / Notices also be sent via postal mail to Commerce Spectrum Management Advisory Committee, National Telecommunications and Information Administration, 1401 Constitution Avenue NW, Room 4600, Washington, DC 20230. It would be helpful if paper submissions also include a compact disc (CD) that contains the comments in one or both of the file formats specified above. CDs should be labeled with the name and organizational affiliation of the filer. Comments must be received five (5) business days before the scheduled meeting date to provide sufficient time for review. Comments received after this date will be distributed to the Committee but may not be reviewed prior to the meeting. Additionally, please note that there may be a delay in the distribution of comments submitted via postal mail to Committee members. Records: NTIA maintains records of all Committee proceedings. Committee records are available for public inspection at NTIA’s Washington, DC office at the address above. Documents including the Committee’s charter, member list, agendas, minutes, and reports are available on NTIA’s website at https://www.ntia.gov/category/csmac. Andrew Coley, Attorney Advisor, National Telecommunications and Information Administration. [FR Doc. 2023–03807 Filed 2–23–23; 8:45 am] BILLING CODE 3510–60–P DEPARTMENT OF COMMERCE Patent and Trademark Office [Docket No.: PTO–C–2023–0002] National Medal of Technology and Innovation Nomination Evaluation Committee Meeting United States Patent and Trademark Office, Department of Commerce. ACTION: Notice of closed meeting. AGENCY: The National Medal of Technology and Innovation (NMTI or Medal) is the nation’s highest honor for technological achievement, bestowed by the president of the United States on America’s leading innovators. The Medal is awarded to individuals, teams (up to four individuals), companies or divisions of companies for their outstanding contributions to America’s economic, environmental and social well-being. The NMTI Nomination Evaluation Committee will meet in a closed session on March 13, 2023. The primary purpose of the meeting is to ddrumheller on DSK120RN23PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:15 Feb 23, 2023 Jkt 259001 discuss the relative merits of the people, teams, and companies nominated for the NMTI. DATES: The meeting will convene on March 13, 2023, at approximately 9 a.m. and adjourn at approximately 4 p.m. ADDRESSES: The meeting will take place at the United States Patent and Trademark Office (USPTO), 600 Dulany St., Alexandria, VA 22314. FOR FURTHER INFORMATION CONTACT: Linda Hosler, Program Manager, National Medal of Technology and Innovation Program, USPTO, at 600 Dulany St., Alexandria, VA 22314; 571– 272–8514; or nmti@uspto.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act (FACA), 5 U.S.C. 1001 et seq., notice is hereby given that the NMTI Nomination Evaluation Committee, chartered to the United States Department of Commerce, will meet at the USPTO campus in Alexandria, Virginia, on March 13, 2023. The Secretary of Commerce is responsible for recommending to the President prospective NMTI recipients. The NMTI Nomination Evaluation Committee evaluates the nominations received via public solicitation and makes its recommendations for the Medal to the Secretary. Committee members are distinguished experts in the fields of science, technology, business, and patent law. They come from both the public and private sectors and are appointed by the Secretary for three-year terms. The NMTI Nomination Evaluation Committee was established in accordance with the FACA. The Committee meeting will be closed to the public, in accordance with the FACA and 5 U.S.C. 552b(c)(6) and (9)(B), because the discussion of the relative merits of the Medal nominations is likely to disclose information of a personal nature that, if shared widely, would constitute an unwarranted invasion of the personal privacy of the nominees. Premature disclosure of the Committee’s recommendations would also likely significantly frustrate the implementation of the Medal program. The Acting Chief Financial Officer and Assistant Secretary of Commerce for Administration, United States Department of Commerce, formally determined on February 17, 2023, pursuant to section 1009(d) of the FACA, that the meeting may be closed because Committee members are concerned with matters that are within the purview of 5 U.S.C. 552b(c)(6) and (9)(B). Due to the closure of this meeting, copies of any meeting minutes will not be available. A copy of the PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 Notice of Determination for Closure of Meeting is available for public inspection at the USPTO. Katherine K. Vidal, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. [FR Doc. 2023–03957 Filed 2–23–23; 8:45 am] BILLING CODE 3510–16–P DEPARTMENT OF COMMERCE United States Patent and Trademark Office [Docket No.: PTO–P–2022–0037] Joint USPTO–FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments United States Patent and Trademark Office, Department of Commerce. ACTION: Request for comments; extension of written comment period. AGENCY: The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is extending the written comment period for the notice titled ‘‘Joint USPTO–FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments’’ that was published in the Federal Register on November 7, 2022, until March 10, 2023. DATES: The comment period for the notice published at 87 FR 67019 is extended. Comments are due by March 10, 2023. ADDRESSES: For reasons of Government efficiency, comments must be submitted through the Federal eRulemaking Portal at www.regulations.gov. This docket closed on February 6, 2023, but is now reopened to accept additional comments. To submit comments via the portal, enter docket number PTO–P– 2022–0037 on the homepage and click ‘‘Search.’’ The site will provide a search results page listing all documents associated with this docket. Find a reference to this document and click on the ‘‘Comment’’ icon, complete the required fields, and enter or attach your comments. Attachments to electronic comments will be accepted as various file types, including Adobe® portable document format (PDF) and Microsoft Word® format. Because comments will be made available for public inspection, information the submitter does not desire to make public, such as an SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1 Federal Register / Vol. 88, No. 37 / Friday, February 24, 2023 / Notices address or phone number, should not be included in the comments. Visit the Federal eRulemaking Portal for additional instructions on providing comments via the portal. If electronic submission of comments is not feasible due to a lack of access to a computer and/or the internet, please contact the USPTO using the contact information below (at FOR FURTHER INFORMATION CONTACT) for special instructions. FOR FURTHER INFORMATION CONTACT: Linda Horner, Administrative Patent Judge, at 571–272–9797 or USPTOFDAcollaboration@uspto.gov. SUPPLEMENTARY INFORMATION: On November 7, 2022, the USPTO, in collaboration with the FDA, published a notice titled ‘‘Joint USPTO–FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments’’ to seek public comments on proposed initiatives for collaboration between the agencies to advance President Biden’s Executive Order on ‘‘Promoting Competition in the American Economy’’ and to support the provision of greater access to medicines for American families. See 87 FR 67019. The USPTO is extending the written comment period until March 10, 2023, to ensure that all stakeholders have a sufficient opportunity to submit comments on the questions presented in the November 7, 2022, notice. Comments previously submitted to the docket through the Federal eRulemaking Portal do not need to be resubmitted. Any comments sent directly to the USPTO after the close of the previous deadline of February 6, 2023, must be submitted through the Federal eRulemaking Portal before the newly extended deadline to be given full consideration. All other information and instructions to commenters provided in the November 7, 2022, notice remain unchanged. Katherine K. Vidal, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. [FR Doc. 2023–03808 Filed 2–23–23; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES BILLING CODE 3510–16–P COMMITTEE FOR PURCHASE FROM PEOPLE WHO ARE BLIND OR SEVERELY DISABLED Procurement List; Additions Committee for Purchase From People Who Are Blind or Severely Disabled. ACTION: Additions to the procurement list. AGENCY: VerDate Sep<11>2014 18:15 Feb 23, 2023 Jkt 259001 This action adds a service to the Procurement List that will be furnished by nonprofit agencies employing persons who are blind or have other severe disabilities. DATES: Date added to the Procurement List: March 26, 2023 ADDRESSES: Committee for Purchase From People Who Are Blind or Severely Disabled, 355 E Street SW, Suite 325, Washington, DC 20024. FOR FURTHER INFORMATION CONTACT: Michael R. Jurkowski, Telephone: (703) 785–6404, or email CMTEFedReg@ AbilityOne.gov. SUPPLEMENTARY INFORMATION: SUMMARY: Additions On 2/23/2022, the Committee for Purchase From People Who Are Blind or Severely Disabled published notice of proposed additions to the Procurement List. This notice is published pursuant to 41 U.S.C. 8503 (a)(2) and 41 CFR 51– 2.3. After consideration of the material presented to it concerning capability of qualified nonprofit agencies to provide the service(s) and impact of the additions on the current or most recent contractors, the Committee has determined that the service(s) listed below are suitable for procurement by the Federal Government under 41 U.S.C. 8501–8506 and 41 CFR 51–2.4. Regulatory Flexibility Act Certification I certify that the following action will not have a significant impact on a substantial number of small entities. The major factors considered for this certification were: 1. The action will not result in any additional reporting, recordkeeping or other compliance requirements for small entities other than the small organizations that will furnish the product(s) and service(s) to the Government. 2. The action will result in authorizing small entities to furnish the product(s) and service(s) to the Government. 3. There are no known regulatory alternatives which would accomplish the objectives of the Javits-WagnerO’Day Act (41 U.S.C. 8501–8506) in connection with the service(s) proposed for addition to the Procurement List. End of Certification Accordingly, the following service(s) are added to the Procurement List: Service(s) Service Type: Grounds Maintenance Mandatory for: U.S. Air Force, Military Family Housing Units, Wright Patterson AFB, OH PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 11903 Designated Source of Supply: Goodwill Easter Seals Miami Valley, Dayton, OH Contracting Activity: DEPT OF THE AIR FORCE, FA8601 AFLCMC PZIO Michael R. Jurkowski, Acting Director, Business Operations. [FR Doc. 2023–03840 Filed 2–23–23; 8:45 am] BILLING CODE 6353–01–P BUREAU OF CONSUMER FINANCIAL PROTECTION [Docket No. CFPB–2023–0015] Agency Information Collection Activities: Comment Request Bureau of Consumer Financial Protection. ACTION: Notice and request for comment. AGENCY: In accordance with the Paperwork Reduction Act of 1995 (PRA), the Consumer Financial Protection Bureau (Bureau or CFPB) requests the extension of the Office of Management and Budget’s (OMB’s) approval of an existing information collection titled ‘‘Evaluation of Financial Empowerment Training Program’’ approved under OMB Number 3170–0067. DATES: Written comments are encouraged and must be received on or before March 27, 2023 to be assured of consideration. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. In general, all comments received will become public records, including any personal information provided. Sensitive personal information, such as account numbers or Social Security numbers, should not be included. FOR FURTHER INFORMATION CONTACT: Documentation prepared in support of this information collection request is available at www.regulations.gov. Requests for additional information should be directed to Anthony May, Paperwork Reduction Act Officer, at (202) 841–0544, or email: CFPB_PRA@ cfpb.gov. If you require this document in an alternative electronic format, please contact CFPB_Accessibility@ cfpb.gov. Please do not submit comments to these email boxes. SUPPLEMENTARY INFORMATION: SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 88, Number 37 (Friday, February 24, 2023)]
[Notices]
[Pages 11902-11903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03808]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

United States Patent and Trademark Office

[Docket No.: PTO-P-2022-0037]


Joint USPTO-FDA Collaboration Initiatives; Notice of Public 
Listening Session and Request for Comments

AGENCY: United States Patent and Trademark Office, Department of 
Commerce.

ACTION: Request for comments; extension of written comment period.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office (USPTO), 
Department of Commerce, in collaboration with the United States Food 
and Drug Administration (FDA), Department of Health and Human Services, 
is extending the written comment period for the notice titled ``Joint 
USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session 
and Request for Comments'' that was published in the Federal Register 
on November 7, 2022, until March 10, 2023.

DATES: The comment period for the notice published at 87 FR 67019 is 
extended. Comments are due by March 10, 2023.

ADDRESSES: For reasons of Government efficiency, comments must be 
submitted through the Federal eRulemaking Portal at 
www.regulations.gov. This docket closed on February 6, 2023, but is now 
reopened to accept additional comments. To submit comments via the 
portal, enter docket number PTO-P-2022-0037 on the homepage and click 
``Search.'' The site will provide a search results page listing all 
documents associated with this docket. Find a reference to this 
document and click on the ``Comment'' icon, complete the required 
fields, and enter or attach your comments. Attachments to electronic 
comments will be accepted as various file types, including 
Adobe[supreg] portable document format (PDF) and Microsoft Word[supreg] 
format. Because comments will be made available for public inspection, 
information the submitter does not desire to make public, such as an

[[Page 11903]]

address or phone number, should not be included in the comments.
    Visit the Federal eRulemaking Portal for additional instructions on 
providing comments via the portal. If electronic submission of comments 
is not feasible due to a lack of access to a computer and/or the 
internet, please contact the USPTO using the contact information below 
(at FOR FURTHER INFORMATION CONTACT) for special instructions.

FOR FURTHER INFORMATION CONTACT: Linda Horner, Administrative Patent 
Judge, at 571-272-9797 or [email protected].

SUPPLEMENTARY INFORMATION: On November 7, 2022, the USPTO, in 
collaboration with the FDA, published a notice titled ``Joint USPTO-FDA 
Collaboration Initiatives; Notice of Public Listening Session and 
Request for Comments'' to seek public comments on proposed initiatives 
for collaboration between the agencies to advance President Biden's 
Executive Order on ``Promoting Competition in the American Economy'' 
and to support the provision of greater access to medicines for 
American families. See 87 FR 67019. The USPTO is extending the written 
comment period until March 10, 2023, to ensure that all stakeholders 
have a sufficient opportunity to submit comments on the questions 
presented in the November 7, 2022, notice.
    Comments previously submitted to the docket through the Federal 
eRulemaking Portal do not need to be resubmitted. Any comments sent 
directly to the USPTO after the close of the previous deadline of 
February 6, 2023, must be submitted through the Federal eRulemaking 
Portal before the newly extended deadline to be given full 
consideration. All other information and instructions to commenters 
provided in the November 7, 2022, notice remain unchanged.

Katherine K. Vidal,
Under Secretary of Commerce for Intellectual Property and Director of 
the United States Patent and Trademark Office.
[FR Doc. 2023-03808 Filed 2-23-23; 8:45 am]
BILLING CODE 3510-16-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.